Marta Mosca

Q: What Schools Are Affiliated With Marta Mosca

Marta Mosca is affiliated with the following schools: Consorzio ICoN, University of Milan, University of Florence

Marta Mosca's AcademicInfluence.com Rankings

Marta Mosca

Philosophy

#9543

World Rank

#13120

Historical Rank

Logic

#6517

World Rank

#8041

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Marta Mosca's Degrees

Doctorate Medicine University of Milan
PhD Rheumatology University of Florence

Why Is Marta Mosca Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marta Mosca's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. (2002) (1813)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (2019) (936)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (2019) (934)
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features (2015) (704)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009) (585)
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force (2014) (526)
EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) (511)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome (2015) (509)
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein (2002) (493)
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. (1996) (483)
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus (2019) (419)
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies (2009) (356)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (2018) (325)
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. (2005) (320)
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy (2006) (318)
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis (2020) (308)
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) (2016) (259)
Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. (1999) (242)
Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual (2007) (209)
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. (2011) (189)
Systemic lupus erythematosus one disease or many? (2012) (170)
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. (2006) (153)
Depression and systemic lupus erythematosus: a systematic review (2013) (150)
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus (2010) (142)
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. (2004) (135)
COVID-19: the new challenge for rheumatologists. (2020) (131)
Undifferentiated connective tissue diseases (UCTD). (2006) (126)
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. (2012) (118)
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. (2015) (116)
The diagnosis and classification of undifferentiated connective tissue diseases. (2014) (114)
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen (2006) (114)
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. (2012) (113)
Prevalence of thyroid dysfunctions in systemic lupus erythematosus. (2010) (113)
The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus (2000) (112)
Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year (1998) (104)
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). (2001) (103)
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity (2014) (100)
The diagnosis and classification of mixed connective tissue disease. (2014) (99)
Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren’s syndrome (2015) (97)
Glucocorticoids in systemic lupus erythematosus. (2011) (97)
How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria (2018) (94)
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. (2012) (92)
Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? (2005) (91)
Systemic sclerosis: state of the art on clinical practice guidelines (2018) (91)
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. (2012) (89)
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. (2016) (89)
Assessing remission in systemic lupus erythematosus. (2006) (88)
Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration (2018) (88)
Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. (2013) (86)
Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review. (2015) (83)
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study (2017) (82)
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. (1999) (80)
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry (2021) (79)
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. (2011) (78)
Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data (2003) (77)
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. (2018) (77)
Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. (2006) (76)
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study (2016) (75)
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. (2016) (74)
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. (2014) (72)
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. (2002) (71)
Low FODMAP Diet: Evidence, Doubts, and Hopes (2020) (68)
Systemic lupus erythematosus: state of the art on clinical practice guidelines (2018) (67)
Undifferentiated CTD: a wide spectrum of autoimmune diseases. (2012) (67)
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation (2001) (65)
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. (2017) (65)
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. (2011) (64)
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study (2018) (63)
A systematic literature review of the economic impact of ankylosing spondylitis. (2012) (63)
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. (2007) (62)
Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. (2002) (62)
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. (2013) (61)
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus (2016) (60)
What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. (2018) (60)
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry (2015) (60)
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus (2015) (58)
“ERS/ATS Task Force onUndifferentiated Forms of CTD-ILD”. An official European RespiratorySociety/American Thoracic Society research statement: interstitial pneumonia withautoimmunefeatures (2015) (55)
Sleep disorders and systemic lupus erythematosus (2014) (54)
2021 DORIS definition of remission in SLE: final recommendations from an international task force (2021) (53)
Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort (2018) (51)
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. (2016) (51)
Treat-to-target in systemic lupus erythematosus: where are we today? (2012) (50)
Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. (2012) (50)
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. (2005) (50)
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. (2006) (49)
Thyroid cancer in systemic lupus erythematosus: a case-control study. (2010) (48)
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases. (2015) (48)
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. (2013) (47)
Off-label use of rituximab for systemic lupus erythematosus in Europe (2016) (47)
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus (2019) (45)
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies. (2015) (45)
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria (2018) (44)
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus. (2015) (44)
Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis (2011) (43)
Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. (2012) (43)
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience (2019) (43)
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting (2020) (42)
Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. (1999) (40)
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. (2012) (40)
Risk factors for osteoporosis in female patients with systemic lupus erythematosus (2004) (39)
The economic impact of gout: a systematic literature review. (2012) (39)
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. (2019) (39)
Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies (2002) (39)
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? (2012) (38)
Antiphospholipid syndrome: state of the art on clinical practice guidelines (2018) (37)
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus (1997) (36)
Relapsing polychondritis: state of the art on clinical practice guidelines (2018) (36)
Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center (2016) (36)
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms? (2014) (36)
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study (2018) (36)
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) (2019) (35)
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection (2020) (34)
Undifferentiated connective tissue diseases in 2004. (2004) (34)
Systemic vasculitis: how little we know about their societal and economic burden. (2012) (34)
Vitamin D in “early” primary Sjögren’s syndrome: does it play a role in influencing disease phenotypes? (2014) (33)
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics (2020) (33)
Treatment of systemic lupus erythematosus. (2001) (33)
[Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre]. (2011) (32)
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities (2020) (32)
COVID-19: the new challenge for rheumatologists. First update. (2020) (32)
Prognostic value of lung ultrasound B-lines in systemic sclerosis. (2020) (31)
Sjögren’s syndrome: state of the art on clinical practice guidelines (2018) (31)
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone (1999) (31)
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. (2012) (31)
Guidelines for the management of essential mixed cryoglobulinemia. (1995) (30)
Cystatin S—a candidate biomarker for severity of submandibular gland involvement in Sjögren’s syndrome (2017) (29)
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity (2013) (28)
Outcome of Pregnancy in Italian Patients with Primary Sjögren Syndrome (2013) (28)
Emerging trends in Sjögren's syndrome: basic and translational research. (2012) (27)
Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response (2019) (27)
Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort (2014) (27)
Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy. (2000) (26)
Associations Between Classification Criteria Items in Systemic Lupus Erythematosus (2020) (26)
Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus (2016) (26)
Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis (2001) (26)
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort (2020) (26)
Systemic lupus erythematosus : clinical features in patients with a disease duration of over 10 years , first evaluation 1 (1999) (26)
Illness perception in systemic lupus erythematosus patients: The roles of alexithymia and depression. (2015) (25)
Mixed connective tissue disease: state of the art on clinical practice guidelines (2018) (25)
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2021) (25)
Cell-free DNA in the plasma of patients with systemic sclerosis (2009) (25)
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren’s Syndrome (2013) (25)
A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up (2020) (25)
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance (2021) (25)
OP0020 Validation of new systemic lupus erythematosus classification criteria (2018) (24)
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging. (2019) (24)
Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). (2007) (24)
The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic. (2017) (24)
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. (2019) (23)
FRI0386 Efficacy and Safety of Off-Label Use of Rituximab in Refractory Lupus: Data from the Italian Multicenter Registry (2014) (23)
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines (2019) (23)
The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders (2018) (23)
The rationale of pharmacoeconomic analysis in rheumatologic indications. (2012) (23)
IgG4-related diseases: state of the art on clinical practice guidelines (2019) (21)
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines (2018) (21)
Cerebral Blood Flow in Depressed Patients with Systemic Lupus Erythematosus (2010) (21)
Treat to target, remission and low disease activity in SLE. (2017) (21)
The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice (2011) (21)
Understanding remission in real-world lupus patients across five European countries (2016) (21)
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease (2019) (20)
Human papillomavirus infection and cervical lesions in rheumatic diseases: a systematic review. (2016) (20)
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis. (2017) (20)
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases. (2019) (20)
A case of undifferentiated connective tissue disease: is it a distinct clinical entity? (2008) (20)
Defining undifferentiated connective tissue diseases: a challenge for rheumatologists (2008) (19)
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine (2019) (19)
Erratum to: MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects (2015) (19)
LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE (2021) (19)
Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus (2020) (19)
Lupus erythematosus and the skin. (2006) (18)
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'. (2014) (18)
Incidence of transient ischemic attacks in the Belluno Province, Italy. First‐year results of a community‐based study. (1996) (18)
Analysis of the evolution of UCTD to defined CTD after a long term follow-up. (2013) (18)
Epidemiology and Management of Neuropsychiatric Disorders in Behçet’s Syndrome (2015) (18)
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings (2017) (18)
[Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD]. (2011) (18)
New drugs in systemic lupus erythematosus: when to start and when to stop. (2013) (17)
SAT0213 PREGNANCY AND UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: OUTCOME AND RISK OF FLARE IN 100 PREGNANCIES (2019) (17)
The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus? (2020) (17)
[Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)"]. (2011) (17)
Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. (2008) (17)
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study (2017) (17)
Are remission and low disease activity state ideal targets for pregnancy planning in Systemic Lupus Erythematosus? A multicentre study. (2021) (16)
Vascular reactivity in patients with undifferentiated connective tissue diseases. (2009) (16)
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines (2019) (16)
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset (2018) (15)
Surviving catastrophic gastrointestinal involvement due to Churg-Strauss syndrome: report of a case. (1997) (15)
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review (2015) (15)
Celiac Disease Prevalence Is Increased in Primary Sjögren’s Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study (2019) (14)
Behçet's syndrome and psychiatric involvement: is it a primary or secondary feature of the disease? (2018) (14)
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews (2008) (14)
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes (2020) (13)
LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus (2007) (13)
Differentiating between UCTD and early-stage SLE: from definitions to clinical approach (2021) (13)
Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome (2018) (13)
Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood (2018) (13)
Neutrophil Extracellular Traps in the Autoimmunity Context (2021) (13)
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies (2021) (12)
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience (2015) (12)
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare (2021) (12)
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus (2020) (12)
Neuropsychiatric questionnaires in systemic lupus erythematosus. (2014) (12)
Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center. (2012) (12)
Pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Practical messages from the EULAR guidelines. (2017) (11)
Integrated backscatter analysis of carotid intima–media complex in patients with systemic lupus erythematosus (2008) (11)
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature (2017) (11)
High sensitivity troponin might be a marker of subclinical scleroderma heart involvement: a preliminary study (2017) (11)
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy. (2019) (11)
Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis? (2019) (11)
Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal? (2013) (11)
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases. (2009) (11)
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature. (2018) (10)
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies (2021) (10)
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres (2018) (10)
MicroRNA-mediated Regulation of Mucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome (2019) (10)
Development of de novo major involvement during follow-up in Behçet’s syndrome (2015) (10)
Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease (2016) (10)
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up (2020) (10)
Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus (2017) (10)
Mixed connective tissue diseases: new aspects of clinical picture, prognosis and pathogenesis. (2014) (10)
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort. (2021) (10)
Treatment of the idiopathic inflammatory myopathies: a retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. (2000) (9)
The social cost of rheumatoid arthritis in Italy: the results of an estimation exercise. (2014) (9)
Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis (2008) (9)
Imaging of joints in systemic lupus erythematosus. (2018) (9)
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study. (2020) (9)
Molecular analysis of VHI+ B lymphocytes in hepatitis C patients (2003) (8)
Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy) (2021) (8)
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials? (2012) (8)
Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day (2020) (8)
Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjögren's syndrome: a preliminary study. (2020) (8)
Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients (2016) (8)
Systemic lupus erythematosus: treatment. (2009) (8)
Usefulness of direct sequencing in the detection of microchimerism in liver transplant recipients. (2000) (8)
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study (2020) (8)
Prognostic value of flow-mediated dilation in patients with systemic lupus erythematosus: a pilot prospective cohort study. (2014) (8)
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? (2019) (8)
Sexual dysfunction in Behçet’s syndrome (2019) (8)
Health information technologies in systemic lupus erythematosus: focus on patient assessment. (2016) (7)
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) (7)
[Adherence to cervical cancer screening in an Italian SLE cohort]. (2011) (7)
Rate of serious infections in Behçet’s disease patients receiving biologic therapies: a prospective observational study (2013) (7)
Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. (2007) (7)
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study (2022) (7)
Clinically Amyopathic Dermatomyositis: Analysis of a Monocentric Cohort (2014) (7)
OP0092 Remission in Sle: Consensus Findings from a Large International Panel on Definitions of Remission in SLE (DORIS) (2015) (7)
Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives. (2016) (6)
Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients (2018) (6)
Shaping the Future of Rare Diseases after a Global Health Emergency: Organisational Points to Consider (2020) (6)
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis? (2013) (6)
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies (2021) (6)
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients (2021) (6)
COVID-19: the new challenge for rheumatologists. One year later. (2021) (6)
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons. (2020) (6)
Systemic vasculitis and the lung (2017) (6)
Platelet GPIIb/IIIa (P1A1/2) polymorphism in SLE: clinical and laboratory association (2003) (6)
Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET) (2018) (5)
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety (2021) (5)
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET. (2022) (5)
Management of digital ulcers in systemic sclerosis (2019) (5)
Prostanoids in scleroderma microangiopathy: clinical and pharmacoeconomic comparison between two intravenous regimens (2021) (5)
FRI0341 Do Patients with SLE at Onset Differ from Mimickers? A Comparison of Clinical and Serological Manifestations in A Multicenter Cohort To Inform The Development of New Classification Criteria for SLE (2016) (5)
Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis. (2021) (5)
FRI0193 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (2019) (5)
Functional and isokinetic assessment of muscle strength in patients with idiopathic inflammatory myopathies (2006) (5)
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis. (2020) (5)
POS0190 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES (2022) (5)
Assessment of Disease Activity in Systemic Lupus Erythematosus (2007) (5)
Mikulicz's disease: a long-term follow-up case report. (2012) (4)
Histopathology of the muscle in rheumatic diseases. (2018) (4)
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome (2021) (4)
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology? (2020) (4)
Response criteria for cutaneous SLE in clinical trials. (2007) (4)
Evaluating the Construct of Damage in Systemic Lupus Erythematosus (2021) (4)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) (2023) (4)
Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients. (2003) (4)
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables (2018) (4)
Erratum to Ruffatti et al. “Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicenter retrospective study” (Thromb Haemost 2014; 112: 727-725) (2014) (3)
Future prospects for salivary proteomics in rheumatology: the example of eosinophil granulomatosis with polyangiitis. (2012) (3)
MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects. (2015) (3)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians (2020) (3)
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey (2021) (3)
Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients. (2013) (3)
AB0380 Treat-to-target in systemic lupus erythematosus: report from the t2t/sle working party (2013) (3)
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study. (2021) (3)
Pregnancy outcomes in women exposed to biologic treatment and affected by chronic arthritis (2010) (3)
FRI0199 EFFECTIVENESS AND SAFETY OF BELIMUMAB IN PATIENTSWITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC STUDY (2019) (3)
AB0806 The impact of dysphagia in idiopathic inflammatory myositis: an online survey of highly-specialised centres (2018) (3)
Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician. (2019) (3)
Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey (2020) (3)
Assessment of swallowing function with oro‐pharyngeal‐esophageal scintigraphy in patients with idiopathic inflammatory myopathies (2019) (3)
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. (2013) (2)
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study (2022) (2)
OP0002 Multicriteria decision analysis for developing new classification criteria for systemic lupus erythematosus (2017) (2)
SAT0387 Validation of Lupus Impact Tracker (LIT) in Five European Clinical Practice Settings (2015) (2)
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022 (2023) (2)
High rate of vertebral refracture after vertebroplasty in patients taking glucocorticoids: a prospective two-year study. (2019) (2)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I) (2023) (2)
OP0019 Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomised, double-blind, placebo-controlled study (2018) (2)
The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the “wound bed score” (2020) (2)
SAT0172 Psychiatric Disorders in Behcet’S Disease: is It a Primary or Secondary Feature of the Disease? (2013) (2)
199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study (2019) (2)
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. (2021) (2)
[Long term functional outcome of idiopathic inflammatory myopathies] (2011) (2)
AB0190 Treatment with Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus (2015) (2)
Anti-C 1 q antibodies in pregnant patients with systemic lupus erythematosus (2006) (2)
FRI0453 Damage Accrual in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Analysis of 53 Patients (2014) (2)
Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis (2022) (2)
Cardiovascular burden in systemic sclerosis: QRISK3 versus Framingham for risk estimation. (2021) (2)
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts (2021) (2)
Undifferentiated connective tissue diseases: A new frontier in rheumatology (2001) (2)
Assessment of multiple organ systems in systemic lupus erythematosus: what will the new guidelines mean? (2010) (2)
Chapter 2 – Assessment of Disease Activity in Systemic Lupus Erythematosus (2007) (2)
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. (2013) (2)
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation. (2021) (2)
THU0287 Glucocorticoids Withdrawal in Systemic Lupus Erythematosus: Myth O Reality? (2016) (2)
THU0271 PERFORMANCE OF THE EULAR/ACR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY DISEASE, ACROSS SEXES AND ETHNICITIES (2020) (1)
UCTD and SLE patients show increased levels of oxidative and DNA damage together with an altered kinetics of DSB repair. (2021) (1)
Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center (2019) (1)
SAT0543 Quality of life in behÇet’s syndrome: the role of patient reported outcome (2018) (1)
A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools. (2021) (1)
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study (2021) (1)
Mixed Connective Tissue Disease (2008) (1)
Alexithymia, mood and illness perception. Preliminary results in systemic lupus erythematosus patients (2011) (1)
FRI0272 Early damage assessment and prediction of damage accrual in primary sjÖgren's syndrome using salivary gland ultrasonography during 2 years of follow-up (2017) (1)
THU0611 Long-term follow-up of 269 children born to mothers with systemic autoimmune diseases: a national survey from 24 rheumatology centers (2017) (1)
FRI0221 GIANT CELL ARTERITIS PRESENTING AS FEVER OF UNKNOWN ORIGIN AND DELAY IN DIAGNOSIS: ANALYSIS OF TWO DIFFERENT DECADES (2020) (1)
270 The discordance between patient and physician perception of the disease: the paradigm of SLE (2019) (1)
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison. (2022) (1)
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort (2021) (1)
AB1150 The european reference network on rare and complex connective tissue and musculoskeletal diseases: ern reconnet (2018) (1)
SAT0248 Baseline clasi-damage is a major predictor of skin response to belimumab in a multicentric cohort of sle patients (2017) (1)
ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN IMAGING POINT OF VIEW (2011) (1)
P.13.4 A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME IMPROVES SYMPTOMS WITHOUT AFFECTING BODY COMPOSITION AND EXTRACELLULAR BODY WATER (2016) (1)
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases (2021) (1)
Unveiling Deficiency of Adenosine Deaminase 2: An Adult Patient With Recurrent Strokes, Vasculitic Ulcers, and Bowel Perforation (2022) (1)
THU0262 Off-Label Use of Rituximab for SLE in Europe: A Comparison to Patients Treated with Conventional Immunosuppressive Medications (2013) (1)
FRI0260 Ultrasound study of pleural profile and chest high-resolution computed tomography (HRCT): diagnostic role in primary sjÖgren's syndrome-induced lung involvement (2017) (1)
THU0304 Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP): A Functional Salivary Biomarker for Primary SjöGren’s Syndrome? (2013) (1)
Erratum to: Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort (2014) (1)
Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life (2022) (1)
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals (2021) (1)
THU0268 Prevalence and features of celiac disease in patients with systemic autoimmune diseases: results of a large multicenter study (2017) (1)
Sleep quality in Behçet’s disease: a systematic literature review (2022) (1)
FRI0373 Long-term follow-up of 320 children born to mothers with systemic autoimmune diseases: a multicentre italian survey from 24 rheumatology centres (2018) (1)
Chronic skin lichenification as unusual presentation of eosinophilic granulomatosis with polyangitis: case report and literature review. (2016) (1)
Adherence to treatment in Behçet's syndrome: a multi-faceted issue. (2021) (1)
prospective study of 1,000 patients syndrome during a 5-year period: a multicenter Morbidity and mortality in the antiphospholipid (2009) (1)
ADVANCES IN THERAPIES FOR SYSTEMIC LUPUS ERYTHEMATOSUS (2015) (1)
An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET (2022) (1)
THU0308 Extensive analysis of T cell receptor gamma (TCRG) gene rearrangements reveals a similar repertoire in eosinophilic granulomatosis with polyangiitis (EGPA) and in hypereosinophilic syndrome (HES) (2017) (1)
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic (2022) (1)
THU0283 Two Year Follow-Up on Biologics Use in 13 Centers - Data from the International Registry for Biologics in SLE (IRBIS) (2013) (1)
Poor sleep quality in systemic lupus eritematosus: does it depend on depression? (2013) (1)
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. (2023) (1)
Do the epithelial cells of salivary glands in Sjögren syndrome express the La-antigen? Preliminary results of an immunohistochemical study (1995) (1)
THU0259 ULTRASOUND OF MAJOR SALIVARY GLANDS IDENTIFIES PATIENTS WITH MORE COMPLEX SALIVARY GLAND HISTOPATHOLOGY BUT NOT MILDER LESIONS (2019) (1)
FRI0153 ULTRA HIGH-RESOLUTION ULTRASOUND (UHFUS) OF LABIAL SALIVARY GLANDS: POTENTIAL APPLICATIONS IN PRIMARY SJÖGREN’S SYNDROME (2020) (1)
982 A Low FODMAP Diet in Irritable Bowel Syndrome Improves Symptoms Without Affecting Body Composition and Extracellular Body Water (2016) (1)
Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren's Syndrome and Overlapping Disorders. (2014) (1)
POS1242 BARICITINIB AND PULSE STEROIDS COMBINED TREATMENT IN SEVERE COVID-19 PNEUMONIA: PRELIMINARY DATA FROM A RHEUMATOLOGIC EXPERIENCE IN INTENSIVE CARE UNIT (2022) (1)
THU0241 Musculoskeletal involvement in inflammatory bowel disease’s patients: a mono centric experience (2018) (1)
POS0782 FOLLICULAR DENDRITIC CELL NETWORKS IN MINOR SALIVARY GLAND BIOPSIES: A MARKER OF DISEASE ACTIVITY AT BASELINE AND DURING THE FOLLOW-UP IN SJÖGREN’S SYNDROME (2021) (0)
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, ﬁrst evaluation 1 (1999) (0)
FRI0465 Quantitative assessment of interstitial lung disease in idiopathic inflammatory myopathies: visual score and computerised processing analysis of high resolution computerised tomography (2018) (0)
POS0771 ULTRA HIGH-FREQUENCY ULTRASOUND (UHFUS) OF MINOR LABIAL SALIVARY GLANDS (MLSGS): DIAGNOSTIC ACCURACY IN ANTI-Ro/SSA POSITIVE AND ANTI-Ro/SSA NEGATIVE PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (pSS) (2022) (0)
FRI0223 EXTRACELLULAR VESICLESAS A SOURCE OF BIOMARKERS IN SJöGREN SYNDROME: A SWATH-MS PROTEOMIC APPROACH (2019) (0)
PS8:161 The disease burden in patients with longstanding systemic lupus erythematosus: focus on health resource use and costs (2018) (0)
PO.7.145 Active skin involvement in patients with systemic lupus erythematosus: analysis of the impact on health-related quality of life and patient perception of health status (2022) (0)
SAT0311 BIOELECTRICAL IMPEDANCE VECTOR ANALYSIS FOR NUTRITIONAL STATUS ASSESSMENT IN SYSTEMIC SCLEROSIS AND ASSOCIATION WITH DISEASE CHARACTERISTICS (2020) (0)
POS0364 UNMET NEEDS IN THE TREATMENT OF EXTRA-RENAL FLARES IN SLE PATIENTS: REAL LIFE EXPERIENCE VS ARTIFICIAL APPROACH (2022) (0)
Immunohistochemical reactivity of anti-La antibodies to the epithelial cells of salivary glands in Sjögren's syndrome (1995) (0)
Mixed cryoglobulinemia: the role of HCV and organ-specific antibodies (1996) (0)
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2022) (0)
FRI0326 Peripheral Lymphadenopathy in Primary Sjögren's Syndrome: Frequency, Pattern of Distribution and Clinical Significance - A Single Center Experience (2016) (0)
FRI0345 Eosinophilic granulomatosis with polyangitis (EGPA): clinical presentation and long-term outcomes of different disease subsets (2013) (0)
Long-termcyclicintravenousiloprost insystemicsclerosis: clinicalexperiencefromasinglecenter (2012) (0)
Telemedicine for rheumatological consultation: the new semeiotics for rheumatic examination. (2021) (0)
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study (2022) (0)
Performance of the EULAR/ACR 2019 Classifi cation Criteria for Systemic Lupus Erythematosus in Men, Diverse Ethnicities, and Early Disease (2019) (0)
AB0503 Therapeutic strategy and short-term outcome in neuropsychiatric systemic lupus erythematosus (2018) (0)
Patterns of inflammation and dysfunction in pSS: identification of proteomic salivary biomarkers correlated with different disease phenotypes. (2015) (0)
P-10Malignancies associated with idiopathicinflammatory myopathies: a 35-yearsretrospective study (2011) (0)
AB0695 Predictive factors of long-term clinical outcome in behcet’s syndrome patients with ocular involvement: does actually the disease tend to grow dim over time? (2018) (0)
An update on autologous stem cell transplantation in severe systemic lupus erythematosus and in early diabetes type 1 (2010) (0)
604 Predicting adverse pregnancy outcomes in women with systemic lupus erythematosus: external validation of the promisse model using multiple independent cohorts (2022) (0)
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group (2023) (0)
3 Use of Antibiotics and Subsequent Risk of Systemic Lupus Erythematosus : A Matched Case-Control Study (2015) (0)
Multiparametric Skin Assessment in a Monocentric Cohort of Systemic Sclerosis Patients: Is There a Role for Ultra-High Frequency Ultrasound? (2023) (0)
AB0510 LUNG ULTRASOUND OF PLEURAL IRREGULARITIES IN SUB-CLINICAL PRIMARY SJÖGREN’S SYNDROME-LUNG INVOLVEMENT: A SINGLE CENTRE EXPERIENCE (2019) (0)
P175 Despite the high rate of response to treatment, lupus nephritis standard of care is still associated with high incidence of chronic kidney disease: a retrospective longitudinal study, from three south-European cohorts of patients in follow-up since 2000 (2020) (0)
AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development (2016) (0)
SAT0179 Mri Pattern of Arthritis in Sle: A Comparative Study with Rheumatoid Arthritis and Healthy Subjects (2014) (0)
O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease (2020) (0)
THE ROLE OFCOMPLEMENT ROLE IN PREGNANCY OF PRIMARY ANTIPHOSPHOLIPID SYNDROME AND HEALTHY WOMEN (2011) (0)
AB0124 NO EFFECTS OF HIGH DOSE 25OH-VITAMIN D SUPPLEMENTATION ON LUPUS NEPHRITIS IN AN ANIMAL MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
AB0064 Spontaneous adipogenesis in bone marrow derived mesenchymal stromal cells after chronic treatment with glucocorticoids (2013) (0)
OC.03.3: Low Fodmaps Diet is Safe and Effective, but Patients’ Perception is not Always the Reality! (2017) (0)
SAT0268 Clinical presentation of nasal involvement in primary sjÖgren's syndrome: a multidisciplinary team approach to a neglected and disabling condition (2017) (0)
CWCMR_A_181326 9..18 (2019) (0)
AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers (2017) (0)
Bilateral hemorrhagic fetal ovarian cyst: a case report (2007) (0)
OP0230 Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies (2014) (0)
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES (2017) (0)
FRI0554 Might the use of a structured clinical chart ad hoc designed for systemic lupus erythematosus assessment improve the quality of care of patients in clinical practice? (2013) (0)
ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC LUPUS ERITEMATOSUS (SLE) AND UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE (UCTD): P1.113 (2004) (0)
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham’s Chorea: A Multicenter Prospective Study (2022) (0)
AB0197 Endothelial dysfunction in a mouse model of SLE: A role for tumor necrosis factor-α? (2013) (0)
AB0407 CARDIOVASCULAR BURDEN IN SYSTEMIC SCLEROSIS: QRISK3 VERSUS FRAMINGHAM FOR RISK ESTIMATION (2021) (0)
FRI0394 Diagnostic Accuracy of Salivary Gland Ultrasonography in Patients with Systemic Sclerosis and Associated Sjögren's Syndrome (2015) (0)
Correction (2008) (0)
AB0191 Prevalence of osteoporosis among female systemic lupus erythematosus patients (2001) (0)
95 Efficacy, damage accrual and predictors of response to belimumab in active sle patients: a large italian multicenter prospective study (2017) (0)
PO.6.133 Dynamical trajectory of glucocorticoid tapering and discontinuation in real-world patients with newly diagnosed systemic lupus erythematosus: the gulp study (2022) (0)
PS6:118 Objective measurements of sleep disorders and psychiatric comorbidities in a cohort of patients with systemic lupus erythematosus (2018) (0)
AB0423 STRATEGIES FOR GLUCOCORTICOID TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS FLARES: A REAL-LIFE EXPERIENCE (2022) (0)
THU0254 ARTICULAR INVOLVEMENT, STEROID TREATMENT AND FIBROMYALGIA ARE THE MAIN DETERMINANTS OF PATIENT-PHYSICIAN DISCORDANCE IN SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience. (2023) (0)
Determinants of vascular damage in Systemic Lupus Erithematosus (2013) (0)
Comment on: Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies: reply. (2020) (0)
FRI0454 Disease Flares and Persistent Low-Level of Disease: Long-Term Outcome in A Cohort of Patients with BehÇEt's Disease (2014) (0)
of patients with systemic lupus erythematosus Disease activity and damage accrual during the early disease course in a multinational inception cohort (2010) (0)
THU0161 Neuropsychiatric involvement and SLE: Performance of a new algorithm for attribution of NP events tested on an italian multicenter cohort (2013) (0)
POS0756 HOW HAS OUR MANAGEMENT OF SLE CHANGED OVER THE LAST THREE DECADES? REAL LIFE DATA FROM A MONOCENTRIC COHORT (2021) (0)
Which extra-renal flare is "difficult to treat" in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches. (2023) (0)
367MO Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective, observational study (2020) (0)
SaO046PREGNANCY IN LUPUS NEPHRITIS: RESULTS OF A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY (2015) (0)
AB1289 TESTING DIFFERENT ITEMS INCLUDED IN THE DEFINITION OF REMISSION IN A MULTICENTRE SLE COHORT (2019) (0)
RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSOUS: THE ITALIAN MULTICENTER REGISTRY (2011) (0)
OP0146 ISOLATED ANTI-Ro52 ANTIBODIES IN SJÖGREN’S SYNDROME: A MILDER INFLAMMATORY PHENOTYPE AT HIGHER RISK FOR FIBROTIC ORGAN INVOLVEMENT (2022) (0)
A Paper Patient-Based Flare Study in SLE (2015) (0)
SP0163 REMISSION IN SLE: WHAT TO AIM FOR? (2019) (0)
SAT0021 Prognostic Value of Salivary Gland Ultrasonography (SGUS) in Primary SjÖGren's Syndrome (2014) (0)
Proteomic Analysis of Whole Saliva as a Promising Tool to Identify Novel Disease Biomarkers in Primary Sjogrens Syndrome (2009) (0)
OC.03.6 AN ADAPTED LOW FODMAP DIET IS SAFE AND EFFECTIVE ALSO IN THE LONG TERM (2018) (0)
Treatment of systemiclupus erythematosus (2001) (0)
Mesenchymal stem cells modulate allogenic response in pancreatic islet transplantation (2005) (0)
Coping with systemic lupus erythematosus in patients’ words (2022) (0)
Mo1967 - An Adapted Low Fodmap Diet is Safe and Effective also in the Long Term (2018) (0)
THU0636 Influenza and meningococcal c vaccinations in a cohort of patients with autoimmune rheumatic diseases: adherence, safety and immunogenicity (2017) (0)
POS0910 PSYCHIATRIC COMORBIDITIES ASSESSMENT: AN UNMET NEED IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES? (2022) (0)
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases. (2022) (0)
FRI0506 Pregnancy in Patients with Undifferentiated Connective Tissue Disease: Clinical Outcomes in 78 Cases (2016) (0)
AB0371 State of the art for treating-to-target in sle: a systematic literature review (2013) (0)
Morphologic ultrasonography of the temporal artery for diagnosis of giant cell arteritis: Brief report (2018) (0)
FRI0155 Α MULTICENTER “AT-RISK” COHORT FOR THE DISCOVERY OF ENVIRONMENTAL, CLINICAL AND MOLECULAR PREDICTORS FOR THE TRANSITION INTO SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (2020) (0)
AB0133 Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein-1 in a murine model of systemic lupus erythematosus (2013) (0)
AB0588 GIANT CELL ARTERITIS: DO DIFFERENT PHENOTYPES OF PRESENTATION MEAN DIFFERENT CLINICAL ENTITIES? (2022) (0)
FRI0607 IDENTIFICATION OF UNMET NEEDS RELATED TO RARE AND COMPLEX CONNECTIVE TISSUE AND MUSCULOSKELETAL DISEASES (RCTDS) ACROSS EU: THE EXPERIENCE OF THE ERN RECONNET (2019) (0)
PSY54 WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS (2019) (0)
Skin Blood Flow in Systemic Sclerosis (2015) (0)
THU0353 Lung ultrasound of pleural irregularities (PI-US) in primary sjÖgren’s syndrome (PSS)-associated interstitial lung disease(ILD): clinical, functional, radiographic and ultrasonographic short-term follow-up (2018) (0)
AB0673 Podiatric Abnormalities in SSC: A Preliminary Report on Consecutive SSC Subjects as Compared to RA Patients (2015) (0)
Cerebral Blood Flow in Depressed Patients with Systemic Lupus Erythematosus GIAMPIEROGIOVACCHINI,MARTAMOSCA,GIANPIEROMANCA,MAURODELLAPORTA,CLAUDIANERI, STEFANOBOMBARDIERI,ANDREACIARMIELLO,H.WILLIAMSTRAUSS,GIULIANOMARIANI, andDUCCIOVOLTERRANI (2010) (0)
Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis. (2013) (0)
POS0909 THE ROLE OF IMACS CORE SET MEASURES TO ROUTINELY EVALUATE THE QUALITY OF LIFE OF IDIOPATHIC INFLAMMATORY MYOPATHIES PATIENTS IN CLINICAL PRACTICE (2022) (0)
Prognosis and Disease Activity (2014) (0)
SAT0260 MUSCULAR INVOLVEMENT OF THE LOWER LIMBS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MRI EVALUATION (2019) (0)
FRI0352 Damage accrual in a large monocentric cohort of primary sjÖgren’s syndrome patients: determinants and impact on patient reported outcomes (2018) (0)
AB0532 CORRELATION WITH THE FREQUENCY OF DISEASE RELAPSES DURING THE FIRST 3 YEARS FROM THE DIAGNOSIS AND DISEASE OUTCOMES IN BEHCET’S SYNDROME (2020) (0)
PS4:79 Long-term follow-up of 320 chilren born to mothers with systemic autoimmune diseases: a multicentre survey from 24 rheumatology centres in italy (2018) (0)
O13 Remission and LLDAS as a target for pregnancy planning in SLE? (2020) (0)
POS0760 MONITORING C3 AND C4 VARIATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PREGNANCIES IS USEFUL TO RECOGNIZE COMPLICATIONS. DATA FROM 2 ITALIAN CENTERS (2021) (0)
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis. (2022) (0)
rCBF SPECT in patients with systemic Lupus Erythematosus and neuropsychiatric involvment: acetazolamide test and SPM analysis (2004) (0)
Patient care pathways for pregnancy in rare and complex rheumatic diseases: results from an international survey. (2023) (0)
THU0339 THE INFLUENCE OF SKIN CALCINOSIS ON THE PROGNOSIS OF DIGITAL ULCERS IN PATIENTS WITH SSC. (2020) (0)
FRI0131 Incidence of renal flares and their prognostic significance in diffuse proliferative glomerulonephritis (2001) (0)
AB0555 SYMPTOMATIC NON-SEROSITIC LUNG INVOLVEMENT IN A MONOCENTRIC COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A REAL-LIFE EXPERIENCE (2022) (0)
Translation, cultural adaptation and validation of the Italian version of the Brief Index of Lupus Damage: the BILDit (2020) (0)
Minor salivarygland biopsy and Sjögren's syndrome: comparative analysis of biopsies amongdifferent Italian rheumatologic centers. Clin Exp Rheumatol. (2012) (0)
FRI0275 In vivo treatment with hydroxichloroquine interferes with ex vivo expansion of mesenchymal stromal cells in a murine model of systemic lupus erythematosus (2013) (0)
[Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide]. (2011) (0)
FP141MULTICENTRIC STUDY COMPARING CYCLOSPORINE, MYCOPHENOLATE MOFETIL AND AZATHIOPRINE IN THE MAINTENANCE THERAPY OF LUPUS NEPHRITIS: 10 YEARS FOLLOW UP (2019) (0)
THU0296 Long-Term Outcome of Diopathic Uveitis: A Prospective Cohort Study (2015) (0)
SAT0598 Outcomes, Rates, and Risk Factors of Transition of Raynaud's Phenomenon To A Connective Tissue Disease: Systematic Review and Meta-Analysis (2016) (0)
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases (2022) (0)
POS0737 LOW PRECONCEPTIONAL COMPLEMENT LEVEL IS RELATED WITH ADVERSE OBSTETRIC OUTCOME IN A MULTICENTRIC COHORT OF PREGNANCY IN PATIENTS WITH APS AND APL POSITIVITY (2021) (0)
THU0004 Patterns of Inflammation and Dysfunction of the Salivary Glands in Patients Newly Diagnosed with SjÖGren's Syndrome (2014) (0)
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? (2020) (0)
The Journal of Rheumatology Volume 32 , no . 2 or both ? Defining unclassifiable connective tissue diseases : incomplete , undifferentiated , (2005) (0)
POS0764 EULAR RECOMMENDATION-BASED QUALITY INDICATORS (QIS) FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): ELABORATION, FINAL SET, PERFORMANCE AND INITIAL VALIDATION (2021) (0)
FRI0640 Structural damage progression in lupus arthritis: a prospective observational study (2017) (0)
SAT0212 Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren’s syndrome (2013) (0)
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) (2023) (0)
Disease-specifi c quality indicators , guidelines , and outcome measures in systemic lupus erythematosus ( SLE ) (2006) (0)
Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study. (2022) (0)
AB0508 Clinically amiopathic dermatomyositis: comparison with classical dermatomyositis and description of clinical outcome (2013) (0)
Sharing good practice in rare diseases: the experience of an innovative hybrid laboratory of narrative medicine and narrative psychology for patients and caregivers living with Behçet's disease. (2022) (0)
The value of outcome measures in autoimmune rheumatic diseases. (2004) (0)
OP0086 Eular Recommendations for Women's Health and the Management of Family Planning, Assisted Reproduction, Pregnancy, and Menopause in Patients With Systemic Lupus Erythematosus and/or the Antiphospholipid Syndrome (2015) (0)
PBI90 THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES (2019) (0)
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine (2019) (0)
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks (2022) (0)
SAT0306 SEMIQUANTITATIVE AND QUANTITATIVE ANALYSIS OF LUNG CT IN THE ASSESSMENT OF INTERSTITIAL LUNG DISEASE IN IDIOPATHIC INFLAMMATORY MYOPATHIES WITH A FOCUS ON ANTISYNTHETASE. (2020) (0)
POS1502-HPR A PHYSICAL EXERCISE PROGRAM FOR THE MANAGEMENT OF FATIGUE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AT THE TIME OF PANDEMIC: A PILOT STUDY (2022) (0)
AB0456 Safety and retention rate of belimumab: data from a multicentric italian study (2017) (0)
SAT0175 ULTRA-HIGH-FREQUENCY ULTRASOUND OF LABIAL SALIVARY GLANDS HIGHLY CORRELATES WITH HISTOPATHOLOGY IN PRIMARY SJÖGREN’S SYNDROME (2019) (0)
POS0767 GLANDULAR INVOLVEMENT IN PRIMARY SJÖGREN SYNDROME PATIENTS WITH INTERSTITIAL LUNG DISEASE (ILD) ONSET: A SINGLE CENTER CROSS-SECTIONAL STUDY (2022) (0)
FRI0192 A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (2019) (0)
FRI0232 PATIENT PERCEPTION OF SLE BURDEN: THE ROLE OF ORGAN DAMAGE (2019) (0)
AB0641 The Role of Oro-Pharyngeal-Esophageal Scintigraphy in The Evaluation of The Swallowing Function in Patients with Idiopathic Inflammatory Myopathies: Short-Term Results of An Ongoing Prospective Study (2016) (0)
POS0751 COMORBIDITY AND LONG-TERM OUTCOME IN PATIENTS WITH CONGENITAL HEART BLOCK: PRELIMINARY DATA OF THE ITALIAN REGISTRY ON THE IMMUNE-MEDIATED CONGENITAL HEART BLOCK (2021) (0)
FRI0263 QUANTITATIVE MUSCLE ULTRASOUND IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES-A PRELIMINARY STUDY (2020) (0)
Cerebral blood flow in depressed patients with systemic lupus erythematosus at baseline and after acetazolamide (2008) (0)
SAT0425 Phenotyping primary sjÖgren’s syndrome (PSS) by using salivary gland ultrasonography: a step forward to individualised therapies (2018) (0)
The Journal of Rheumatology erythematosus.anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus Prevalence and clinico-serological correlations of anti-alpha-enolase, (2006) (0)
AB0694 Assessment of quality of life and coping in patients with SLE (2013) (0)
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study (2016) (0)
FRI0323 A “Composite-Index” Approach for Defining Salivary Gland Inflammation, Dysfunction and Its Impact on Patient-Reported Outcomes: A Role for Salivary Gland Ultrasonography? (2016) (0)
FRI0344 Novel biomarkers of subclinical endothelial dysfunction in behÇet's syndrome: evaluation of cross-sectional distensibility and intima-media-thickness in a hospital-based population (2017) (0)
THU0685 Cardiovascular risk estimation in sle patients: a comparison of three algorithms (2018) (0)
Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients (2013) (0)
THU0273 Factors Associated with Absenteeism, Presenteeism and Activity Impairment in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) (2015) (0)
Bioelectrical Impedance Vector Analysis for Nutritional Status Assessment in Systemic Sclerosis and Association With Disease Characteristics (2020) (0)
SAT0469 “interstitial lung disease in idiopathic inflammatory myopathies: ultrasound assessment of pleural irregularities and comparison with high resolution computed tomography” (2018) (0)
Low Fodmaps Diet is Safe and Effective, but Patients' Perception is not Always the Reality! (2017) (0)
FRI0296 Diagnostic performance of salivary gland ultrasonography in the early stages of pss in a real-life clinical setting (2013) (0)
POS0123 MAJOR SALIVARY GLAND ULTRASONOGRAPHY AND MRI WITH DIFFUSION WEIGHTED IMAGING (DWI) AS COMPLEMENTARY TOOLS TO IDENTIFY FEATURES OF MALT IN PRIMARY SJÖGREN’S SYNDROME (pSS): A SINGLE CENTER CROSS SECTIONAL STUDY (2022) (0)
Treatment With Anifrolumab for Discoid Lupus Erythematosus. (2022) (0)
FRI0383 Laser speckle contrast imaging (LASCA) is a valid aid in the differential diagnosis of raynaud’s phenomenon (2013) (0)
AB0731 Thyroid disorders assessment: an unmet need in patients with idiopathic inflammatory myopathies? (2022) (0)
AB0683 Troponin Might be a Candidate Marker for Subclinical Scleroderma Heart Involvement (SHI): A Preliminary Report (2015) (0)
T.08.1 ROLE OF ENDOSCOPIC RESECTION MARGIN (R1) IN THE CLINICAL OUTCOME OF PATIENTS WITH NEUROENDOCRINE NEOPLASIA (2023) (0)
AB0441 PREDICTORS OF CLASI RESPONSE OVER TIME IN A MULTICENTRIC REAL LIFE COHORT OF SLE PATIENTS TREATED WITH BELIMUMAB (2022) (0)
THU0354 Osteopororsis and Fragility Fractures in Systemic Lupus Erythematosus: Something New to be Explored? (2015) (0)
FRI0090 The presence of microchimerism in systemic lupus erythematosus: preliminary data (2001) (0)
OP0125 THE MANAGEMENT OF PREGNANCY IN AUTOIMMUNE RHEUMATIC DISEASES: ANALYSIS OF 758 PREGNANCIES FROM THE PROSPECTIVE NATIONWIDE P-RHEUM.IT STUDY (THE ITALIAN REGISTRY OF PREGNANCY IN THE RHEUMATIC DISEASES) (2022) (0)
PRO140 KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT. (2019) (0)
FRI0376 Dyslipidemia as a newly recognisedfactor associated with damage accrual in early diagnosed sle: results from the multicenter early lupus project inception cohort (2018) (0)
FRI0150 USEFULNESS OF SALIVARY GLAND ULTRASONOGRAPHY IN THE ASSESSMENT OF SALIVARY GLAND ACTIVITY AND DAMAGE IN PRIMARY SJÖGREN’S SYNDROME: A SINGLE CENTER EXPERIENCE (2020) (0)
Undifferentiated CTD: a widespectrum of autoimmune diseases (2012) (0)
POS1232 LONG-TERM OUTCOMES OF COVID-19 VACCINATION IN PATIENTS WITH RARE AND COMPLEX CONNECTIVE TISSUE DISEASES: AN AD-INTERIM ANALYSIS OF ERN-ReCONNET VACCINATE STUDY (2022) (0)
AB0683 Parameters of arterial stiffness in a population of SLE patients with long disease duration: Something new to be examined? (2013) (0)
The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies. (2022) (0)
Comparison of different forms of Raynaud's phenomenon by LASCA proximal-distal gradient perfusion. (2023) (0)
Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings (2013) (0)
Systemic Vasculitis and Pregnancy: Maternal and Neonatal Outcome of 20 Prospectively Followed Pregnancies (2011) (0)
AB0647 Arthritis in systemic lupus erythematosus: A patient’s perspective (2013) (0)
POS0789 APPLICATION OF THE NEW ACR/EULAR 2019 CLASSIFICATION CRITERIA OF SYSTEMIC LUPUS ERYTHEMATOSUS TO A INCEPTION, MONOCENTRIC COHORT OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASES POPULATION AT ONSET OF THE DISEASE (2021) (0)
AB0618 A SNAPSHOT OF DISEASE ACTIVITY IN PATIENTS WITH BEHCET’S SYNDROME: PREDICTIVE FACTORS AND RELATIONSHIP WITH QUALITY OF LIFE (2019) (0)
POS0860 ULTRA-HIGH FREQUENCY ULTRASOUND FOR DIGITAL ARTERIES: COMPLETING THE CHARACTERIZATION OF VASCULOPATHY IN SYSTEMIC SCLEROSIS (2022) (0)
AB1359 Translation, cultural adaptation and validation of the italian version of the bild: the bildit (2018) (0)
184 Patient perception of SLE burden: the role of disease activity, comorbidities and treatment (2019) (0)
FRI0514 Anti-neutrophil cytoplasmic antibodies positivity in interstitial lung disease patients (2018) (0)
Clinical and LASCA preliminary data on selexipag efficacy for the treatment of digital vasculopathy in systemic sclerosis. (2023) (0)
FRI0352B COMPARISON OF TWO ILOPROST REGIMENS IN TERMS OF ECONOMIC IMPACT AND EFFECTIVENESS (2019) (0)
THU0664 Translation, cultural adaptation and validation of the systemic lupus activity questionnaire (SLAQ) in a cohort of italian patients with systemic lupus erythematosus (SLE) (2017) (0)
Treatment management of patients with systemic lupus erythematosus: a delphi consensus analysis (2022) (0)
231. TRENDS IN LONG-TERM OUTCOMES IN EGPA: A SINGLE CENTER EXPERIENCE (2019) (0)
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography (2022) (0)
POS0693 EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS IN REAL-LIFE SETTING: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC, PROSPECTIVE COHORT (2021) (0)
FRI0346 Fever of unknown origin as potential reason for delays in recognition of giant cell arteritis (2013) (0)
THU0346 Determinants of sonographic glandular damage in a large cohort of patients with primary sjÖgren’s syndrome and its impact on salivary gland dysfunction (2018) (0)
THU0284 WHAT DO HEMATOLOGICAL ABNORMALITIES TELL US IN SLE? RESULTS FROM TWO INDEPENDENT MULTICENTER EUROPEAN SLE COHORTS (2019) (0)
P26.08: Bilateral hemorrhagic fetal ovarian cyst: a case report (2007) (0)
RISK FACTORS AND CO-MORBIDITIES ASSOCIATED WITH NEURO-PSYCHIATRIC INVOLVEMENT IN SLE: A SUB-ANALYSIS IN 413 PATIENS WITHOUT ANTIPHOSPHIOLIPID ANTIBODIES (2011) (0)
01 We need better classification criteria for lupus (2019) (0)
004. USEFULNESS OF BIOMARKERS OF EOSINOPHIL ACTIVATION IN MONITORING EGPA DISEASE ACTIVITY (2019) (0)
POS0778 ULTRA HIGH-RESOLUTION ULTRASOUND (UHFUS) OF LABIAL GLANDS IS A STRONG PREDICTOR OF SALIVARY GLAND HISTOPATHOLOGY IN SJÖGREN’S SYNDROME (PSS) (2021) (0)
POS0753 PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A MONOCENTRIC COHORT OF PATIENTS WITH LONGSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (2022) (0)
An Opportunity to Harmonise the Approach to Patients' Care Pathways for Rare and Complex Diseases: RarERN Path™ (2022) (0)
Exploring patient’s experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach (2022) (0)
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes. (2023) (0)
SAT0491 Clinical features and complications in a large international cohort of antimda5 patients: a challenge for the future (2018) (0)
SAT0183 LUPUS NEPHRITIS: A RETROSPECTIVE LONGITUDINAL STUDY LOOKING FOR CHRONIC RENAL DISEASE ASSOCIATED FACTORS, FROM THREE SOUTH-EUROPEAN COHORTS OF PATIENTS IN FOLLOW-UP SINCE 2000 (2019) (0)
FRI0313 DOES INTERSTITIAL LUNG DISEASE REPRESENT A REAL COMORBIDITY IN SPONDYLOARTHRITIS PATIENTS? RESULTS FROM AN ULTRASOUND MONOCENTRIC PILOT STUDY (2020) (0)
FRI0347 Predictive factors of long-term clinical outcome in patients with ocular involvement secondary to behcet’s disease. (2013) (0)
AB0166 The Effect of a Treatment with Allogenic Mesenchimal Stromal Cells (MSCS) on Urinary Biomarkers in a Mouse Model of Systemic Lupus Erythematosus (2015) (0)
AB0391 Sleep disorders in systemic lupus erythematosus patients: a cross sectional study (2013) (0)
OP0046 MULTICENTRIC STUDY COMPARING CYCLOSPORINE, MYCOPHENOLATE MOFETIL AND AZATHIOPRINE IN THE MAINTENANCE THERAPY OF LUPUS NEPHRITIS: 10 YEARS FOLLOW UP (2019) (0)
Pregnancy in patients with inflammatory arthritis taking biological drugs: a multicenter Italian registry (2011) (0)
THU0052 Allogenic Mesenchymal Stromal Cells Transplantation in A Murine Model of Sle (2014) (0)
Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later (2023) (0)
Recommendation 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (2019) (0)
Defining patient with dermatomyositis successfully tretaed with intravenous immunoglobulin therapy (2005) (0)
Gender differences in SLE: report from a cohort of 417 Caucasian patients (2023) (0)
378P MGMT status influences prognosis of patients with IDH wild type grade III gliomas (2020) (0)
AB0593 Disease Activity and Quality of Life in BehÇEt's Disease: the Role of Patients Reported Outcomes (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marta Mosca?

Marta Mosca is affiliated with the following schools: